A seasoned human resources executive, Walsh joins Orthofix from ResMed Inc., a San Diego-based medical device company, where she served most recently as Vice President of Transformation.
LEWISVILLE, Texas (BUSINESS WIRE), July 16, 2024: Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer.
A seasoned human resources executive, Walsh joins Orthofix from ResMed Inc., a San Diego-based medical device company, where she served most recently as Vice President of Transformation. During her tenure at ResMed, she also held multiple HR leadership positions, including Vice President, People, SaaS, where she led the HR team and people strategy for ResMed’s SaaS Business Unit with more than 2,500 global employees. Earlier in her career, Walsh held multiple HR leadership positions at Illumina, Inc., Sempra Energy, and Invitrogen (now Thermo Fisher Scientific), serving in talent management, recruiting, and international assignments.
“I am excited to welcome Stephanie to the company,” said Orthofix Chief People and Business Operations Officer Lucas Vitale. “Stephanie brings a depth of leadership experience across the HR function, including talent management strategies, diversity efforts, and organizational design that will help further drive talent as a key differentiator for Orthofix.”
“I am thrilled to join Orthofix to lead the HR function at such a transformational point for the company,” said Walsh. “I look forward to working with the Orthofix leadership team to optimize people and organizational capabilities that help strengthen the company and support future growth.”
Walsh has a Bachelor of Arts in Psychology from Indiana University.
As an inducement to enter into employment with Orthofix, Walsh was granted (i) time-based vesting restricted stock units that settle into 16,603 shares of common stock and (ii) stock options to purchase 38,231 shares of common stock. The time-based vesting restricted stock units vest in equal tranches over three years. The stock options vest upon the achievement of service-based criteria. The grants, which were approved by Orthofix’s Board of Directors, were made under standalone inducement award agreements approved pursuant to NASDAQ Marketplace Rule 5635(c)(4).
Do Follow: CIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter
About us:
CIO News is the premier platform dedicated to delivering the latest news, updates, and insights from the CIO industry. As a trusted source in the technology and IT sector, we provide a comprehensive resource for executives and professionals seeking to stay informed and ahead of the curve. With a focus on cutting-edge developments and trends, CIO News serves as your go-to destination for staying abreast of the rapidly evolving landscape of technology and IT. Founded in June 2020, CIO News has rapidly evolved with ambitious growth plans to expand globally, targeting markets in the Middle East & Africa, ASEAN, USA, and the UK.
CIO News is a proprietary of Mercadeo Multiventures Pvt Ltd.
